The Valley Desk

NCT06188741 · Interventional trial

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

Overall registry status Recruiting

Phase 2

Conditions Neurofibromatosis 1, Plexiform Neurofibroma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov